The Canadian Association of Pharmacy in Oncology (CAPhO) is a member-directed association that promotes, supports and advances oncology pharmacy practice. CAPhO is a recognized leader of oncology pharmacy in Canada, with members including pharmacists, pharmacy technicians, assistants and students. We support the provision of safe and effective oncology pharmacy services to oncology patients. Mentorship, education and research support are some of the ways that CAPhO contributes to member professional development. CAPhO advocates for oncology pharmacy excellence through the collaboration and engagement with healthcare providers, patients and other organizations.

Learn more about CAPhO through our website and our blogs (the Compass), and become a member today.

Latest News & Updates

Join us for a conversation about self leadership in pharmacy with Maria Anwar.

CAPhO Connections Podcast Series keeps the oncology pharmacy community informed on matters affecting you and updated on CAPhO’s news related to education, awards, advocacy and research.

Viatris Inc. announced that Abevmy® is now available in Canada. Abevmy, is a biosimilar to Roche’s Avastin® (bevacizumab) and has been authorized for use by Health Canada across four oncology indications.

Many pharmacist-led and CAPhO-supported research initiatives are contributing significantly to advancing cancer care in Canada.